Ethiopia vs San Marino: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Ethiopia
81.0%
in 2025
San Marino
81.0%
in 2025
Ethiopia rank
113th
San Marino rank
113th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Ethiopia
- San Marino
How they compare
Ethiopia currently reports 81.0% against 81.0% in San Marino, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was San Marino ahead.
Ethiopia ranks 113th and San Marino ranks 113th of 194 countries.
Across the 3 decades both report, Ethiopia averaged higher in 1 and San Marino in 1.
Head to head by decade
| Decade | Ethiopia | San Marino | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 46.4% | 24.3% | 22.1% | Ethiopia |
| 2020s | 73.7% | 81.5% | 7.8% | San Marino |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Ethiopia or San Marino?
- Ethiopia, at 81.0% against 81.0% in San Marino as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Ethiopia and San Marino?
- 0.0%, with Ethiopia ahead.
- How many years of comparable data are there for Ethiopia and San Marino?
- 18 years are reported by both, from 2008 to 2025.
- How do Ethiopia and San Marino rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Ethiopia ranks 113th and San Marino ranks 113th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.